Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Financial Flexibility Index
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥144.78 Million (operating CF CN¥-1.04 Million minus capex CN¥145.81 Million) represents 0% of total liabilities (CN¥1.78 Billion). Check Wanbangde Pharmaceutical Holding Group C (002082) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wanbangde Pharmaceutical Holding Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Wanbangde Pharmaceutical Holding Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Wanbangde Pharmaceutical Holding Group C (002082) cash conversion ratio.
Annual Financial Flexibility Index for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Wanbangde Pharmaceutical Holding Group Co Ltd. Explore Wanbangde Pharmaceutical Holding Group C cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥893.63 Million | CN¥603.98 Million | CN¥1.78 Billion | ▲ +277.2% |
| 2024 | 0.13x | CN¥208.65 Million | CN¥120.22 Million | CN¥1.57 Billion | ▲ +265.6% |
| 2023 | 0.04x | CN¥55.85 Million | CN¥-72.87 Million | CN¥1.54 Billion | ▲ +170.1% |
| 2022 | -0.05x | CN¥-72.42 Million | CN¥-239.65 Million | CN¥1.40 Billion | ▼ -128.2% |
| 2021 | 0.18x | CN¥299.14 Million | CN¥22.09 Million | CN¥1.63 Billion | ▼ -27.4% |
| 2020 | 0.25x | CN¥710.25 Million | CN¥151.01 Million | CN¥2.80 Billion | ▲ +204.1% |
| 2019 | 0.08x | CN¥157.29 Million | CN¥-248.69 Million | CN¥1.89 Billion | ▼ -72.1% |
| 2018 | 0.30x | CN¥335.03 Million | CN¥135.40 Million | CN¥1.12 Billion | ▲ +4424.1% |
| 2017 | 0.01x | CN¥3.28 Million | CN¥-17.60 Million | CN¥496.58 Million | ▼ -99.5% |
| 2016 | 1.22x | CN¥319.74 Million | CN¥310.71 Million | CN¥261.85 Million | ▲ +598.8% |
| 2015 | 0.17x | CN¥47.23 Million | CN¥16.76 Million | CN¥270.28 Million | ▼ -76.0% |
| 2014 | 0.73x | CN¥185.22 Million | CN¥140.31 Million | CN¥254.69 Million | ▲ +6.4% |
| 2013 | 0.68x | CN¥246.80 Million | CN¥234.35 Million | CN¥361.07 Million | ▲ +31.6% |
| 2012 | 0.52x | CN¥243.65 Million | CN¥202.73 Million | CN¥469.09 Million | ▲ +53.3% |
| 2011 | 0.34x | CN¥132.86 Million | CN¥-1.44 Million | CN¥392.22 Million | ▼ -37.5% |
| 2010 | 0.54x | CN¥206.29 Million | CN¥162.26 Million | CN¥380.46 Million | ▲ +30.1% |
| 2009 | 0.42x | CN¥128.15 Million | CN¥68.13 Million | CN¥307.39 Million | ▼ -67.7% |
| 2008 | 1.29x | CN¥399.99 Million | CN¥253.06 Million | CN¥309.46 Million | ▲ +442.4% |
| 2007 | 0.24x | CN¥122.13 Million | CN¥12.45 Million | CN¥512.51 Million | ▲ +21.4% |
| 2006 | 0.20x | CN¥96.97 Million | CN¥3.50 Million | CN¥493.85 Million | ▲ +0.8% |
| 2005 | 0.19x | CN¥99.08 Million | CN¥11.23 Million | CN¥508.84 Million | ▼ -58.3% |
| 2004 | 0.47x | CN¥130.99 Million | CN¥32.69 Million | CN¥280.48 Million | ▲ +1.6% |
| 2003 | 0.46x | CN¥74.93 Million | CN¥37.01 Million | CN¥163.05 Million | — |